Leadman Biochemistry updates on idle funds wealth management strategy

Beijing Leadman Biochemistry Co., Ltd. has disclosed recent activities regarding its wealth management initiatives utilizing idle self-owned funds. The company's board of directors and supervisory board approved the use of up to 700 million yuan for wealth management, to be rolled over within 12 months from March 4, 2025. This strategy involves purchasing cash management and wealth management products from financial institutions such as banks, securities companies, trust companies, and fund management companies, prioritizing high safety and liquidity with moderate risk.

The announcement details recent redemptions from bank wealth management products. For instance, a structured deposit with Huaxia Bank, maturing on October 14, 2025, yielded 400,400 yuan on an initial investment of 80 million yuan, with an annualized return of 1.00%-2.03%. Other redemptions include a China Minsheng Bank structured deposit of 30 million yuan that matured on September 30, 2025, yielding 9,200 yuan, and two Huaxia Bank structured deposits totaling 70 million yuan, yielding 157,100 yuan and 201,200 yuan respectively.

As of the disclosure date, the company and its subsidiaries hold a total of 290.8052 million yuan in wealth management products. These include structured deposits from commercial banks, notice deposits, and cash management products from Minsheng Bank, all within the authorized board limit. The company emphasizes risk control measures, including strict selection of investment targets, real-time monitoring by the finance department, auditing by the audit department, and oversight by independent directors and supervisors, to ensure capital safety and maximize returns.